Recent News and Webcasts:
Welcome to Inhibitex.com
Inhibitex is a clinical-stage biopharmaceutical company dedicated to the development of innovative
products that can treat or prevent serious infections. We are applying our expertise in the development
of a portfolio of high-value, differentiated infectious disease therapies, each of
which has the potential to significantly improve upon existing standards of care and improve patient outcomes. Our
pipeline addresses significant viral and bacterial infections, including herpes zoster
(shingles), chronic hepatitis C, and S. aureus infections.
